Erratum Vol. 8, No. 1

180 Emerging Infectious Diseases • Vol. 8, No. 2, February 2002 18. National Committee for Clinical Laboratory Standards. Method for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard. NCCLS document M7-A3. Villanova (PA): The Committee; 1993. 19. Hooper DC. New uses for new and old quinolones and the challenge of resistance. Clin Infect Dis 2000;30:243-54. 20. Tee W, Mijch A, Wright E, Yung A. Emergence of multidrug resistance in Campylobacter jejuni isolates from three patients infected with human immunodeficiency virus. Clin Infect Dis 1995;21:634-8. 21. Burnens AP, Heitz M, Brodard I, Nicolet J. Sequential development of resistance to fluoroquinolones and erythromycin in an isolate of Campylobacter jejuni. Zentralbl Bakteriol 1996;283:314-21. 22. Lu PL, Hsueh PR, Hung CC, Chang SC, Luh KT, Lee CY. Bacteremia due to campylobacter species: high rate of resistance to macrolide and quinolone antibiotics. J Formos Med Assoc 2000;99:612-7. 23. Steinbigel NH. Erythromycin, lincomycin, and clindamycin. In: Mandell GL, Douglas RG, Bennett JE, editors. Principles and practice of infectious diseases, 3rd ed. New York: Churchill Livingstone; 1990. p. 309. 24. Van Duong D, Binns CW, Van Le T. Availability of antibiotics as overthe-counter drugs in pharmacies: a threat to public health in Vietnam. Trop Med Int Health 1997;2:1133-9. 25. Thamlikitkul V. Antibiotic dispensing by drug store personnel in Bangkok, Thailand. J Antimicrob Chemother 1988;21:125-31. 26. Visitsunthorn N, Komolpis P. Antimicrobial therapy in Plesiomonas shigelloides-associated diarrhea in Thai children. Southeast Asian J Trop Med Public Health 1995;26:86-90.